Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer.
Int J Mol Sci. 2019 Apr 29;20(9):2112. doi: 10.3390/ijms20092112.
Int J Mol Sci. 2019.
PMID: 31035676
Free PMC article.